Altum Pharmaceuticals Inc. has closed a new round of financing, raising $#Research Note – Subscribers ONLY – where and how did you get your news? Subscribe today to see our research on this and all other subscriber ONLY news. Be informed!#
Vancouver based Altum Pharmaceuticals Inc. is a private biopharmaceutical company engaged in clinical and commercial development of novel natural and pharmaceutical compounds, to treat cancer and autoimmune disorders. Altum focuses on development and acquisition of novel products specializing on the commercialization of existing products for cancer and diseases mediated by acute and chronic inflammatory reactions.
photo credit: Altum Pharmaceuticals
Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.
Latest posts by Ted Liu (see all)
- Audax Private Equity’s Lifemark Health Group acquires AssessMed - December 5, 2019
- Persistence Capital Partners launches MedSpa Partners - December 5, 2019
- Thoughtexchange secures $20M Series B led by IVP - December 5, 2019